Antonio Cubillo - Hospital Universitario Madrid Sanchinarro

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 169 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Circulating Tumor DNA Using a Plasma-Only Assay Predicts Survival in Patients with Oligometastatic Colorectal Cancer after Definitive Therapy

Enrique Sanz-Garcia,Paloma Peinado, Adrián Peláez, Elena Gonzalez Lopez-Aranda, Rafael Álvarez-Gallego,César Muñoz, Carmen Toledano, Luka Mihic, Justo Ortega, Almudena Lazaro, Begoña Martinez Montesino, Cristina Bressel, Alicia Gonzalo, Ovidio Hernando, Mercedes Lopez,Carmen Rubio,Isabel Fabra,Yolanda Quijano,Emilio Vicente,Antonio Cubillo

Journal of gastrointestinal oncologyno. 2 (2025): 580-590

Cited0Views0WOSBibtex

Real-world Effectiveness and Safety of Second- or Third-Line Pegylated Liposomal Irinotecan Plus 5-Fluorouracil and Folinic Acid in Pancreatic Ductal Adenocarcinoma in Spain

Rafael Alvarez-Gallego,Roberto Pazo-Cid, Borja Lopez de San Vicente,Teresa Macarulla, Eva Martinez, Fernando Garicano,Irene Hernandez,Monica Granja,Ismael Ghanem, Joaquina Martinez, Paula Ribera, Roberto Diaz, Jose Ignacio Martin Valades, Maria Cristina Angeles,Antonio Cubillo

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2025)

Cited0Views0WOSBibtex

Tislelizumab (TIS) Plus Chemotherapy (CT) Vs Placebo (PBO) Plus CT in HER2-negative Advanced or Metastatic Gastric or Gastro-Esophageal Junction Adenocarcinoma (GC/GEJC): PDL1 Biomarker Analysis from RATIONALE-305

M. Moehler, D-Y. Oh,K. Kato,J. Tabernero, M. Cruz-Correa,L. S. Wyrwicz,R. A. Pazo Cid,A. Cubillo,L. Evesque,L. Fornaro,E. Dotan, C. Morgan, L. Li, Y. Xu,T. Sheng,S. Yang,H. Hu,R-H. Xu

ANNALS OF ONCOLOGY (2024): S160-S161

Cited0Views0Bibtex

Binimetinib in Combination with Nivolumab or Nivolumab and Ipilimumab in Patients with Previously Treated Microsatellite-Stable Metastatic Colorectal Cancer with RAS Mutations in an Open-Label Phase 1b/2 Study

Elena Elez,Antonio Cubillo,Pilar Garcia Alfonso,Mark R. Middleton,Ian Chau, Baha Alkuzweny,Ann Alcasid,Xiaosong Zhang,Eric Van Cutsem

BMC Cancerno. 1 (2024): 1-10

Cited0Views0WOSBibtex

Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan with 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients with Rectal Cancer in a Watch-and-Wait Program

César Muñoz, María-C Riesco Martinez,Lisardo Ugidos, Pilar García-Alfonso,Rafael Alvarez-Gallego,Paloma Peinado, Carmen Toledano, Luka Mihic-Góngora, Justo Gabriel Ortega Anselmi, Enrique Sanz Garcia,Emilio Vicente,Yolanda Quijano,Hipólito J Durán,Eduardo Díaz,Valentina Ferri,Carmen Rubio,Ovidio HernandoRequejo, Mercedes López González,Susana Prados, Ulpiano López, María Allona, Virginia PérezDueñas, María Angeles Perez-Escutia,Antonio Cubillo

American journal of clinical oncologyno. 3 (2024): 142-147

Cited0Views0WOSBibtex

397MO Tislelizumab (TIS) Plus Chemotherapy (CT) Vs Placebo (PBO) Plus CT in HER2-negative Advanced or Metastatic Gastric or Gastro-Esophageal Junction Adenocarcinoma (GC/GEJC): PD-L1 Biomarker Analysis from RATIONALE-305

M. Moehler, D-Y. Oh, K. Kato,J. Tabernero, M. Cruz-Correa,L.S. Wyrwicz,R.A. Pazo Cid,A. Cubillo,L. Evesque,L. Fornaro,E. Dotan, C. Morgan, L. Li, Y. Xu,T. Sheng, S. Yang,H. Hu,R-H. Xu

Annals of Oncology (2024): S160-S161

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn